Immune system

Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Thursday, February 23, 2023
Tissue, DNA, Immune system, Research, Engineering, G&A, Hepatocyte, Haemophilia, R, Liver, Hepatology, Therapy, LNP, D, Spleen, Vaccine, Cryptocurrency

CAMBRIDGE, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, outlined its strategic priorities for 2023 and reported fourth quarter and full year 2022 financial results.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co .
  • (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, outlined its strategic priorities for 2023 and reported fourth quarter and full year 2022 financial results.
  • “Generation Bio is aiming to be the new modality leader for non-viral DNA therapeutics.
  • This type of ctLNP could extend the reach of nucleic acid therapeutics to new tissues and cell types beyond the liver.

ManukaGuard Promotes Research, Awareness and Education for Kids ENT Health Month

Retrieved on: 
Thursday, February 23, 2023
Research, General Health, Online Retail, Specialty, Consumer, Fitness & Nutrition, Retail, Children, Science, Alternative Medicine, Vitamins, Supplements, Health, Bacteria, Common, Diagnosis, Immune system, Choking, Virus, IG, Ear, Immunity, Nose, Sinusitis, Nature, Parent, Caregiver, Education, Gear, Otitis, Edible, Dentistry, Vaccine

In honor of February being designated as Kids ENT Health Month, ManukaGuard , the nation’s leading provider of natural, medical grade manuka honey products, is calling for more research, enhanced education, and public awareness of pediatric diseases and conditions related to the ear, nose and throat – with an emphasis on illness prevention.

Key Points: 
  • In honor of February being designated as Kids ENT Health Month, ManukaGuard , the nation’s leading provider of natural, medical grade manuka honey products, is calling for more research, enhanced education, and public awareness of pediatric diseases and conditions related to the ear, nose and throat – with an emphasis on illness prevention.
  • From earaches to choking hazards, to repetitive sinus infections and flu, kids suffer from a variety of ailments that require prompt diagnosis and treatment.
  • Kids ENT Health Month is a yearly campaign held every February to offer parents and caregivers the latest information and resources about pediatric ear, nose, and throat disorders.
  • “Honestly, every month should be Kids ENT Health Month,” added Gear.

Xencor Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Thursday, February 23, 2023
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, ENPP3, Pembrolizumab, CD28, Caris, Cancer, RCC, Immune system, Cowen, Psoriasis, Laboratory, IND, CLDN6, Investment, Patient, Biology, R, Janssen, Neoplasm, CD20, Renal cell carcinoma, Bispecific monoclonal antibody, Therapeutic index, Sale, Antibody, CD3, Cytokine, Protein engineering, Novartis, Kidney cancer, Vir, G&A, Prostate, Atopic dermatitis, Vaccine, Cryptocurrency, Online shopping, Barclays, Regulatory T cell, Astellas Pharma, MorphoSys, Alexion

Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022

Key Points: 
  • Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022
    Cash, cash equivalents, receivables and marketable debt securities totaled $613.5 million as of December 31, 2022, compared to $664.1 million on December 31, 2021.
  • Total revenue for the fourth quarter ended December 31, 2022 was $21.6 million compared to $154.0 million for the same period in 2021.
  • General and administrative (G&A) expenses for the fourth quarter ended December 31, 2022 were $12.8 million compared to $11.4 million for the same period in 2021.
  • ET (1:30 p.m. PT) to discuss the full year 2022 financial results and provide a corporate update.

Bloom Nutrition Rapidly Expands Retail Presence, Entering Walmart's Growing Health and Wellness Category

Retrieved on: 
Friday, February 24, 2023
Vitamin, Skin, Immune system, Amazon, Nutrient, Probiotic, The Non-GMO Project, Superfood, Vegetable, Digestion, Health, Grocery store, Target, Walmart, Bloom

LOS ANGELES, Feb. 24, 2023 /PRNewswire/ -- Bloom Nutrition, the fan-favorite wellness company with coveted, easy-to-use and effective health supplements, announced its expanding retail presence by launching into Walmart retail stores nationwide and online. Furthering Bloom's mission to provide approachable, accessible and delicious health products to all. The brand will specifically be stocking the shelves within Walmart's wellness aisles with their viral Greens & Superfoods powder.

Key Points: 
  • LOS ANGELES, Feb. 24, 2023 /PRNewswire/ -- Bloom Nutrition , the fan-favorite wellness company with coveted, easy-to-use and effective health supplements, announced its expanding retail presence by launching into Walmart retail stores nationwide and online .
  • The brand will specifically be stocking the shelves within Walmart's wellness aisles with their viral Greens & Superfoods powder .
  • As the brand quickly accelerates its retail distribution, consumers will be able to find Bloom products in more than 1787 Walmart locations.
  • Bloom is also available direct-to-consumer nationwide through Amazon and is a best-selling supplement with over 21 thousand 5-star reviews.

CHOP Researchers Identify Molecules that Optimize Immune Presentation of Antigens across the Human Population

Retrieved on: 
Friday, February 24, 2023
Philadelphia, Knowledge, DOI, Genetic distance, MHC, Doctor of Philosophy, Protein, Allele, Mouse, Cancer, University, Antigen, Immune system, Associate, HLA, Child, Library, Cell, Peptide, CHOP, Chicken, Children's Hospital of Philadelphia, Human, Science Advances, Immunization, Champaign–Urbana metropolitan area, Computation, Membrane protein, Hospital, Fine chemical, Vaccine

PHILADELPHIA, Feb. 24, 2023 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) have identified variants of a chaperone molecule that optimizes the binding and presentation of foreign antigens across the human population, which could open the door to numerous applications where robust presentation to the immune system is important, including cell therapy and immunization. The findings were published today in Science Advances.

Key Points: 
  • When foreign peptides are identified, they trigger a cascade that allows cytotoxic T cells to eliminate intruders.
  • For a peptide to be presented to the immune system, it needs to be loaded on a folded MHC-I protein.
  • Several molecules facilitate this process, including proteins known as molecular chaperones, which assist with MHC-I folding.
  • To solve this problem, the CHOP researchers analyzed three different TAPBPR proteins: one from humans, one from chickens, and one from mice.

Intoleran Is Guiding Those With Food Intolerances Toward a Happier, Healthier Future

Retrieved on: 
Friday, February 24, 2023
Food allergy, Immune system, Ecosystem, Create, Enzyme, Food, Knowledge, Entire, Irritable bowel syndrome, Quality of life, Food intolerance, Mayo Clinic, IBS, Animal feed, Dairy

FORT LAUDERDALE, Fla., Feb. 24, 2023 /PRNewswire/ -- Digestive enzymes are a popular way to address a food intolerance. Unlike a food allergy (which involves an overreaction by the immune system, someone with a food intolerance is simply unable to break down certain foods. Mayo Clinic details that the causes of a food intolerance can come from conditions such as irritable bowel syndrome (IBS), sensitivity to food additives, or simply a lack of the particular enzyme required to break down and digest certain foods.

Key Points: 
  • FORT LAUDERDALE, Fla., Feb. 24, 2023 /PRNewswire/ -- Digestive enzymes are a popular way to address a food intolerance.
  • Unlike a food allergy (which involves an overreaction by the immune system, someone with a food intolerance is simply unable to break down certain foods.
  • The Dutch health brand Intoleran has created a range of high-quality digestive enzyme supplements that can help with a wide variety of different food intolerances and their accompanying symptoms.
  • This "digestive support ecosystem" refers to a multi-faceted repository of resources that Intoleran has created for its customers.

Shuttle Pharmaceuticals Expands Laboratory Space to Advance Drug Development Pipeline and Diagnostic Capabilities

Retrieved on: 
Thursday, February 23, 2023
Cancer, RT, Immune system, Brain, Investigational New Drug, TCG, National Cancer Institute, Research, National Institutes of Health Clinical Center, FDA, Patient, Trial of the century, Acceleration, Shuttle, Bangladesh Technical Education Board, Glioblastoma, Pharmaceutical industry

The new laboratory space, located in Gaithersburg, Maryland, is located within the Maryland Biotech Corridor.

Key Points: 
  • The new laboratory space, located in Gaithersburg, Maryland, is located within the Maryland Biotech Corridor.
  • Shuttle Pharma's platform of sensitizers offers a pipeline of product candidates designed to address the urgent clinical need for new radiation sensitizer agents.
  • The Company's pipeline includes Ropidoxuridine, its lead clinical sensitizer drug candidate, to sensitize rapidly growing cancer cells and selective histone deacetylase inhibitors to sensitize cancer cells and stimulate the immune system.
  • "The expansion of our laboratory space is critical to the advancement of our drug development pipeline and acceleration of our broader diagnostic capabilities on predictive biomarkers," commented Shuttle Pharma's Chairman and CEO, Anatoly Dritschilo, M.D.

SleepGift Launches Their EMF Protective Blankets to Improve Sleep and Wellbeing

Retrieved on: 
Wednesday, February 15, 2023
System, Radiation, Serotonin, Doctor of Philosophy, MD, Immune system, EMF, Spectrum, Anxiety, Melatonin, Life, EMF measurement, Sleep, Plant, Human, ADHD, CO2, Infrared, Animal, Health, Insomnia, Hormone, Transformer

Dr Ureten says that EMF radiation is damaging to all forms of life - humans, animals, plants, and microorganisms.

Key Points: 
  • Dr Ureten says that EMF radiation is damaging to all forms of life - humans, animals, plants, and microorganisms.
  • However, using EMF-emitting electronic devices is virtually unavoidable in today's modern society, so SleepGift created a line of products that help people reduce their exposure to EMF radiation.
  • To shield people from EMFs, SleepGift's durable and washable blankets contain silver-infused fabric, which blocks up to 99% of EMF radiation.
  • Aside from promoting better sleep and providing protection from radiation, SleepGift's blankets are also sustainable and are made from natural materials.

EQS-News: Abivax publishes a prospectus in the context of its capital increase

Retrieved on: 
Thursday, February 23, 2023
Equity carve-out, Prospectus, Immune system, Euronext Paris, CET, Patient, Therapy, AMF, VWAP, EUR, Pharmaceutical industry, Medical device

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • The prospectus is composed of:
    the 2022 Universal Registration Document filed with the AMF on April 28, 2022, under number D.22-0372;
    the amendment of the 2022 Universal Registration Document filed with the AMF on September 2, 2022, under number D.22-0372-A01;
    the amendment of the 2022 Universal Registration Document filed with the AMF on February 23, 2023, under number D.22-0372-A02;
    the summary of the prospectus.
  • The Company draws the reader’s attention to the fact that its press release issued on February 22, 2023, relating to the Capital Increase included a clerical error on the calculation of the subscription price discount to the 15-day VWAP.
  • The discount calculated based on the VWAP for the trading days between February 1, 2023, and February 21, 2023, (instead of February 6, 2023, to February 21, 2023) is equal to 6.26%, as indicated in the prospectus (instead of 5.05%, as indicated in the press release dated February 22, 2023).

Todos Medical Provides Corporate Update

Retrieved on: 
Thursday, February 23, 2023
Medicine, Cancer, Mortality, Biomarker, Dementia, Laboratory developed test, CCR5, Emergency Use Authorization, LDT, Organization, CyberGraphX, Patient, PCR, Quest Diagnostics, COVID, West New York, New Jersey, Immune system, Collection, Partnership, School, OTCQB, Physician, Marketing, Breast cancer, RSV, Disease, Risk, CLIA, Government, Disability, PHE, National Public Health Emergency Team (2020), Pharmaceutical industry, Vaccine, Pharma, Long COVID, CBD, Vizient, Inc.

New York, NY, and Tel Aviv, ISRAEL, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today provided a corporate update for shareholders.

Key Points: 
  • New York, NY, and Tel Aviv, ISRAEL, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today provided a corporate update for shareholders.
  • We believe that COVID and Long COVID will both drive significant increases in cancer and dementia in the years ahead, making the diagnostics Todos is developing even more important for patients and physicians.
  • The Company recently formed Todos Botanicals to serve as the long-term solution for manufacturing of our 3CL Pharma subsidiary’s Tollovid product(s).
  • The Company is now pursuing a national stock exchange listing with the New York Stock Exchange through the NYSE American Exchange.